eye disease

Large layoffs of employees Wooden figures of people going to the exit

Opthea lays off 65% of staff after back-to-back phase 3 flops

Days after two flops sank an eye disease asset, the biotech revealed plans to lay off 65% of its staff and operate with a skeleton crew to save money.

Nick Paul Taylor Apr 10, 2025 7:52am

Tenvie takes off with $200M, assets and exec from Denali

Jan 8, 2025 8:00am

mRNA therapy reduced post-surgery eye scarring in rabbits

Nov 27, 2024 2:00pm

eye doctor opthalmology phoropter glasses eye disease vision

AlloVir finds new identity via eye disease biotech merger

Nov 8, 2024 9:05am

Ocuphire to transform into gene therapy biotech via Opus buyout

Oct 23, 2024 5:31am

Two thirteen-lined ground squirrels fight over a piece of food

Hibernating squirrels hold protein that clears cataracts: study

Sep 20, 2024 11:58am